CardioVia
PrivateLast Round
Grant
May 1, 2019
Total Funding Raised
$56,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CardioVia operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Grant round in May 2019.
CardioVia is a medical device company that develops minimally invasive technology for safe and precise access to the heart's surface (pericardial space) to treat cardiovascular diseases and arrhythmias.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioVia Comparables
Compare CardioVia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiEP, Inc. | 87% | |
| CIRCA Scientific | 85% | |
| CorNav Corporation | 81% |
For institutional investors. Book with your work email.
CardioVia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2019 | ||||
| Seed | Apr 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CardioVia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
| NGT HealthCare II | Seed |
| Yissum Research Development Company of the Hebrew University of Jerusalem | Seed |
| Hadasit - Hadassah Medical Center's Technology Transfer Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 151% MoM, reaching 1.3K.
- May 16, 2026
Monthly visitors increased 43% MoM.
For institutional investors. Book with your work email.
CardioVia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CardioVia's valuation, stock price, and market status.
Is CardioVia a public or private company?
CardioVia is a private company.
What is the current stock price of CardioVia?
CardioVia is a private company, so its shares have no public market price. Caplight tracks CardioVia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CardioVia worth (valuation)?
Valuation information for CardioVia is not publicly available.
Can I buy CardioVia stock?
CardioVia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CardioVia's last funding round?
CardioVia's most recent funding round was Grant on May 1, 2019.
Who are the main investors in CardioVia?
Key investors in CardioVia include Israel Innovation Authority, NGT HealthCare II, Yissum Research Development Company of the Hebrew University of Jerusalem, Hadasit - Hadassah Medical Center's Technology Transfer Company.
Will CardioVia IPO soon?
No public IPO plans have been announced for CardioVia.
How can I track CardioVia secondary market activity?
Caplight tracks bids, offers, and trades in CardioVia's shares on secondary markets.